Feng Xie
机构: Professor, Department of Clinical Epidemiology and Biostatistics
主页: mcmaster.ca
每年引用次数
引用次数
引用: 8,083
H-指数: 47
I10-指数 : 165
出版物: 365
Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF): A cluster randomized trial of a computerized clinical decision support tool.
Jafna L Cox , Ratika Parkash , Gary A Foster , Feng Xie
American Heart Journal 224 35 -46
3
2020
A new frontier in treatment of advanced melanoma: Redefining clinical management in the era of immune checkpoint inhibitors.
Oren Levine , Tahira Devji , Feng Xie
Human Vaccines & Immunotherapeutics 13 ( 8) 1765 -1767
2
2017
Total or partial knee replacement? Cost-utility analysis in patients with knee osteoarthritis based on a 2-year observational study.
Feng Xie , Ngai-Nung Lo , Jean-Eric Tarride , Daria O’Reilly
European Journal of Health Economics 11 ( 1) 27 -34
27
2010
Eliciting preferences to the EQ-5D-5L health states: discrete choice experiment or multiprofile case of best-worst scaling?
Feng Xie , Eleanor Pullenayegum , Kathryn Gaebel , Mark Oppe
European Journal of Health Economics 15 ( 3) 281 -288
23
2014
Between-country heterogeneity in EQ-5D-3L scoring algorithms: how much is due to differences in health state selection?
Eleanor M. Pullenayegum , Kuhan Perampaladas , Kathryn Gaebel , Brett Doble
European Journal of Health Economics 16 ( 8) 847 -855
12
2015
Health Utility Book (HUB)-Cancer: Protocol for a Systematic Literature Review of Health State Utility Values in Cancer.
Michael James Zoratti , Ting Zhou , Kelvin Chan , Oren Levine
MDM policy & practice 4 ( 2) 2381468319852594
2019
Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura.
Feng Xie , Gord Blackhouse , Nazila Assasi , Kaitryn Campbell
Clinical Therapeutics 31 ( 5) 1082 -1091
14
2009
Economic evaluations conducted by Canadian health technology assessment agencies: where do we stand?
Jean-Eric Tarride , Catherine Elizabeth McCarron , Morgan Lim , James M. Bowen
International Journal of Technology Assessment in Health Care 24 ( 4) 437 -444
14
2008
Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese.
Feng Xie , Nan Luo , Gord Blackhouse , Ron Goeree
International Journal of Technology Assessment in Health Care 24 ( 1) 87 -95
19
2008
P4-165: COST-UTILITY ANALYSIS OF DEMENTIA CARE MANAGEMENT: RESULTS OF THE CLUSTER-RANDOMIZED, CONTROLLED, INTERVENTIONAL TRIAL DELPHI-MV
Bernhard Michalowsky , Feng Xie , Tilly Eichler , Ingo Kilimann
Alzheimers & Dementia 14
2018
Cost-effectiveness of a collaborative dementia care management—Results of a cluster-randomized controlled trial
Bernhard Michalowsky , Feng Xie , Tilly Eichler , Johannes Hertel
Alzheimers & Dementia 15 ( 10) 1296 -1308
15
2019
Cost-effectiveness of dabigatran and rivaroxaban compared with warfarin for stroke prevention in patients with atrial fibrillation.
Ye Wang , Feng Xie , Ming Chai Kong , Lai Heng Lee
Cardiovascular Drugs and Therapy 28 ( 6) 575 -585
14
2014
Cost‐Effectiveness of Osimertinib in Treating Newly Diagnosed, Advanced EGFR‐Mutation‐Positive Non‐Small Cell Lung Cancer
Bin Wu , Xiaohua Gu , Qiang Zhang , Feng Xie
Oncologist 24 ( 3) 349 -357
38
2019
Multinational Evidence of the Applicability and Robustness of Discrete Choice Modeling for Deriving EQ-5D-5L Health-State Values
Paul F. M. Krabbe , Nancy J. Devlin , Elly A. Stolk , Koonal K. Shah
Medical Care 52 ( 11) 935 -943
34
2014
Forty-two systematic reviews generated 23 items for assessing the risk of bias in values and preferences' studies.
Juan Jose Yepes-Nuñez , Yuan Zhang , Feng Xie , Pablo Alonso-Coello
Journal of Clinical Epidemiology 85 21 -31
14
2017
Assessment of preference for hormonal treatment-related health states among patients with breast cancer
Xing-Yu Tan , Maung-Maung Aung , Mei-Ing Ngai , Feng Xie
Value in health regional issues 3 ( 1) 27 -32
6
2014
Economic Evaluation of Anastrozole Versus Tamoxifen for Early Stage Breast Cancer in Singapore
Vivianne Shih , Alexandre Chan , Feng Xie , Yu Ko
Value in health regional issues 1 ( 1) 46 -53
4
2012
Health State Utility Assessment for Breast Cancer
Vivianne Shih , Alexandre Chan , Feng Xie , Yu Ko
Value in health regional issues 1 ( 1) 93 -97
12
2012
Validity, Feasibility and Acceptability of Time Trade-Off and Standard Gamble Assessments in Health Valuation Studies: A Study in a Multiethnic Asian Population in Singapore
Hwee-Lin Wee , Shu-Chuen Li , Feng Xie , Xu-Hao Zhang
Value in Health 11 ( 1) S3 -S10
21
2008
A Study on Indirect and Intangible Costs for Patients with Knee Osteoarthritis in Singapore
Feng Xie , Julian Thumboo , Kok-Yong Fong , Ngai-Nung Lo
Value in Health 11 S84 -S90
27
2008